Different signaling interpretations by PKC eta and theta control T cell function and exhaustion
Authors:
- Thomas H. MannTMThomas H. Mann
- Shixin MaSMShixin Ma
- Anna-Maria GlobigAGAnna-Maria Globig
- Michael LaPortaMLMichael LaPorta
- Hokyung K. ChungHCHokyung K. Chung
- Bryan McDonaldBMBryan McDonald
- Majid GhassemianMGMajid Ghassemian
- Steven ZhaoSZSteven Zhao
- Hubert TsengHTHubert Tseng
- Yagmur FarsakogluYFYagmur Farsakoglu
Preprint
Abstract
SUMMARY: Chronic antigen signaling drives CD8 + T cell exhaustion (T EX ) in cancer and chronic infection. However, how the kinase cascades downstream of the T cell receptor drive exhaustion is not understood. We found that continuous agonism of protein kinase C (PKC) causes degradation of PKC theta, but not PKC eta, and induces terminal T EX cells. During chronic infection, PKC theta is necessary to maintain the progenitor exhausted (T EX-PROG ) cells, and thus the antigen-specific T cell response, while agonism of PKC eta promotes terminal exhaustion (T EX-TERM ) in vitro and in vivo . The cascades downstream of these kinases are distinct, with PKC theta promoting activity of canonical PKC targets in the MAPK and CDK families, while eta promotes activity of other targets, including casein kinase I G2 (CK1G2). Expression of an engineered, degradation-resistant PKC theta, or deletion of the gene encoding CK1G2, improves T cell function and tumor control. Our illustration of multiple therapeutic avenues arising from targeting PKC highlights its centrality in T EX differentiation and its clinical potential in cancer immunotherapy. Highlights: PKC theta sustains T cell function while PKC eta promotes terminal exhaustion PKC theta and eta drive distinct phospho-cascades to oppose each other’s differentiation instructions An engineered, degradation-resistant PKC theta improves T cell responses in chronic infection and cancer Ablation of kinase CK1G2 downstream of PKC eta improves anti-tumor T cell responsesKeywords
This publication has 77 references indexed in Scilit:
- Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerCell, 2020
- SnapShot: The RNA ExosomeCell, 2019
- De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell RejuvenationCell, 2017
- Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell SequencingCell, 2017
- Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor SuppressorCell, 2015
- Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 SignalingCell, 2013
- Protein kinase Cη activates NF-κB in response to camptothecin-induced DNA damageBiochemical and Biophysical Research Communications, 2011
- Cotranslational and Posttranslational N-Glycosylation of Polypeptides by Distinct Mammalian OST IsoformsCell, 2009
- PKCη is localized in the Golgi, ER and nuclear envelope and translocates to the nuclear envelope upon PMA activation and serum-starvation:Cellular Signalling, 2006
- FOXP3 Controls Regulatory T Cell Function through Cooperation with NFATCell, 2006